The State of Biotech

Close to the Edge

Search and Replace: Andrew Anzalone Details How Genome Editing Went Prime Time on “Close to the Edge”

Decoding Genomic Diversity with deCODE Genetics CEO Kári Stefánsson on “Close to the Edge”

From Knowledge, Drug Power: Andrew Hopkins Discusses AI-Based Development on “Close to the Edge”

Shehnaaz Suliman, MD, MPhil, Discusses Targeted Respiratory Therapies on “Close to the Edge”

Helen Sabzevari, PhD, of Precigen Connects Cancer and the Immune System on “Close to the Edge”

Front Row

GEN Edge Live